Sevoflurane promotes endothelium-dependent smooth muscle relaxation in isolated human omental arteries and veins

Anesth Analg. 2004 Aug;99(2):423-8, table of contents. doi: 10.1213/01.ANE.0000121771.78755.F4.

Abstract

Anesthesia with sevoflurane is accompanied by vasodilatation. This could be due to the effects of sevoflurane on endothelium-dependent relaxation. We measured muscle tension of isolated human omental arteries and veins in response to substance P or glyceryl trinitrate in the presence of sevoflurane (0%, 1%, 2%, or 4%). Vascular levels of guanosine 3', 5'-cyclic monophosphate were measured with enzyme-linked immunosorbent assay. Substance P induced an endothelium- and concentration-dependent relaxation in omental vessels that was not affected by sevoflurane. In the presence of L-N(G)-nitroarginine methyl ester (nitric oxide synthase inhibitor), KCl (prevention of hyperpolarization), or both, sevoflurane at 4% enhanced the relaxation in the arteries (P < 0.05). In the vein segments, the relaxation was enhanced by sevoflurane at 4% in the presence of KCl and 2% and 4% in the presence of both L-N(G)-nitroarginine methyl ester and KCl (P < 0.05). The glyceryl trinitrate-induced endothelium-independent relaxation was enhanced by sevoflurane at 4% in both artery and vein segments (P < 0.05). Substance P increased the levels of guanosine 3', 5'-cyclic monophosphate similarly in the presence and absence of sevoflurane. These results show that sevoflurane, in contrast to its effect in animal models, promotes endothelium-dependent relaxation in human omental arteries and veins via an enhancement of the smooth muscle response to relaxing second messengers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anesthetics, Inhalation / pharmacology*
  • Arteries / drug effects
  • Cyclic GMP / physiology
  • Endothelium, Vascular / physiology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • In Vitro Techniques
  • Male
  • Methyl Ethers / pharmacology*
  • Middle Aged
  • Muscle Relaxation / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase Type III
  • Nitroglycerin / pharmacology
  • Omentum / blood supply
  • Potassium Chloride / pharmacology
  • Regional Blood Flow / drug effects
  • Sevoflurane
  • Substance P / pharmacology
  • Vasodilator Agents / pharmacology
  • Veins / drug effects

Substances

  • Anesthetics, Inhalation
  • Enzyme Inhibitors
  • Methyl Ethers
  • Vasodilator Agents
  • Substance P
  • Sevoflurane
  • Potassium Chloride
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Nitroglycerin
  • Cyclic GMP
  • NG-Nitroarginine Methyl Ester